During the past decade, UO Ematologia II Facoltà di Medicina e Chirurgia Università Federico II conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UO Ematologia II Facoltà di Medicina e Chirurgia Università Federico II" #1 collaborator was "Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "UO Ematologia II Facoltà di Medicina e Chirurgia Università Federico II" are "Follicular Lymphoma" (2 trials) and "Non Hodgkin Lymphoma" (1 trials). Many other conditions were trialed in "UO Ematologia II Facoltà di Medicina e Chirurgia Università Federico II" in a lesser frequency.

Most popular intervention types in "UO Ematologia II Facoltà di Medicina e Chirurgia Università Federico II" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "LR-CHOP21" (1 trials) and "Rituximab, Mitoxantrone, Bendamustine" (1 trials). Other intervention names were less common.

The vast majority of trials in "UO Ematologia II Facoltà di Medicina e Chirurgia Università Federico II" are 2 trials for "All" genders.

Currently, there are NaN active trials in "UO Ematologia II Facoltà di Medicina e Chirurgia Università Federico II". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in UO Ematologia II Facoltà di Medicina e Chirurgia Università Federico II, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UO Ematologia II Facoltà di Medicina e Chirurgia Università Federico II, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".